Combination of | |
---|---|
DTaP vaccine | Vaccine |
Inactivated poliovirus vaccine | Vaccine |
Hib vaccine | Vaccine |
Clinical data | |
Trade names | Pentacel, Pediacel, Infanrix IPV + Hib, others |
AHFS/Drugs.com | FDA Professional Drug Information |
Routes of administration | Intramuscular injection |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number |
DTaP-IPV/Hib vaccine is a5-in-1combination vaccine that protects againstdiphtheria,tetanus,whooping cough,polio, andHaemophilus influenzae type B.[1][2]
Its generic name is "diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and haemophilus B conjugate vaccine", and it is also known asDTaP-IPV-Hib.[1]
DTaP-IPV/Hib vaccine is administered to young children to immunise againstdiphtheria,tetanus,pertussis,poliomyelitis, and diseases caused byHaemophilus influenzae type B.[1]
A branded formulation marketed in the United States is Pentacel, manufactured bySanofi Pasteur.[3]
Pentacel is known in the UK and Canada as Pediacel.[4][5]
An equivalent vaccine marketed in the UK and Canada byGlaxoSmithKline is Infanrix IPV + Hib.[5] This is a two-part vaccine. TheDTaP-IPV component is supplied as a sterile liquid, which is used to reconstitute lyophilized (freeze-dried)Hib vaccine.[citation needed]
Pentaxim is a liquid formulation marketed bySanofi Pasteur.[6]
It is only licensed for young children.[7] The United StatesFood and Drug Administration has approved[when?] the vaccine for children from age 6 weeks up to age 5 years.[1] It was used in the UK until 2017, following which a6-in-1 vaccine became available containing the additional protection againstHepatitis B.[2]